People · Operator
Named in public records as an officer, director or promoter · active 2017–2018 · Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Arix Bioscience plc | — | Biotech | Series B | $39.4M | $850.9M | 2017 |
FRANZ HUMER at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside FRANZ HUMER on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David U'Prichard | 1 | 4 |
| Trevor Jones | 1 | 3 |
| Christopher Evans | 1 | 2 |
| JONATHAN PEACOCK | 1 | 2 |
| John Banham | 1 | 2 |
| JAMES RAWLINGSON | 1 | 1 |
| John Mutton Of Furness | 1 | 1 |
| JOHN HUTTON OF FURNESS | 1 | 1 |
| MEGHAN MAIR FITZGERALD | 1 | 1 |
| JOSEPH ANDERSON | 1 | 1 |
| GILES MAIR KERR | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.